Sign In
Buy CGIX
$1.08
+0 (+0%)
At Close: May 27, 2022
A Look At Benzinga Pro's Most-Searched Tickers For July 16, 2019
04:44pm, Tuesday, 16'th Jul 2019Cancer Genetics Sharply Higher After Interpace Buys Biopharma Unit
12:44pm, Tuesday, 16'th Jul 2019
Cancer Genetics (NASDAQ: CGIX ) shares are trading sharply higher after Interpace Diagnostics (NASDAQ: IDXG ) said it purchased the Biopharma Services unit of the Cancer Genetics. Interpace Diagnostic
Mid-Afternoon Market Update: Crude Oil Down 4%; Cancer Genetics Shares Spike Higher
12:00am, Tuesday, 16'th Jul 2019
Interpace Diagnostics Group, Inc. (IDXG) (“Interpace” or the “Company”), announced today that it has acquired assets and certain liabilities constituting the Biopharma Services business of Can
Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer
11:00am, Monday, 24'th Jun 2019
Innovate Biopharmaceuticals, Inc. (INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, today announced the appointment of E
